Delivery Order SPE2DB25D3108-SPE2DB25FPDLL
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $1,051.05 firm fixed-price delivery order on June 17, 2025, by the Defense Logistics Agency to supply Trulicity 1.5 mg/0.5 ml pens. This delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 18, 2025, by the Defense Logistics Agency for the supply of Trulicity 1.5 mg/0.5 mL pens valued at $7,736.88. The contract carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competition. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania, with an...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 9, 2025, by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $22,414.82. The contract is a firm fixed price delivery order with an ultimate completion date of September 10, 2025, and was awarded without a set-aside designation through competitive procurement. Performance will be executed at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,252.25 by the Defense Logistics Agency on July 23, 2025. The contract calls for delivery of Trulicity 3 mg/0.5 ml pens (0.5ml units), a diabetes medication commonly used within military and federal healthcare systems. This is a non-set-aside award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitive delivery order award from the Defense Logistics Agency valued at $1,174.94 for Trulicity 0.75 mg/0.5 ml pen medication. The contract carries a firm fixed price structure with an ultimate completion date of July 25, 2025, and was awarded on July 24, 2025. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,281.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 21, 2025, with completion expected by July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $1 billion through December 2026. The pharmaceutical product will be delivered to...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $1,351.35 from the Defense Logistics Agency for Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This competitively awarded, firm fixed price delivery order was issued on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation and is performed at the contractor's Conshohocken facility. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order from the Defense Logistics Agency valued at $5,650.58 for Trulicity 4.5 mg/0.5 ml pen injections. Awarded on September 23, 2025, with completion expected by September 24, 2025, this firm fixed-price contract represents a small-value pharmaceutical supply order under a non-set-aside acquisition. The delivery order is issued under AmerisourceBergen's...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDLLDelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,101.07 by the Defense Logistics Agency (DLA) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract, utilizing firm fixed pricing with no set-aside designation, calls for the delivery of Trulicity 1.5 mg/0.5 mL pens in 0.5 mL quantities to support federal medical supply needs. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceuticals and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp's federal contracting demonstrates significant capability in pharmaceutical distribution to defense and veteran healthcare systems. The company's extensive portfolio of delivery orders with DLA covers multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. All reviewed contract awards have been competitively awarded with firm fixed pricing structures, ranging from small-value transactions to orders exceeding $45,000, reflecting the company's versatility in fulfilling federal medical procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/24/25 |